IBDEI0W1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14260,0)
 ;;=G62.2^^83^822^119
 ;;^UTILITY(U,$J,358.3,14260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14260,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy d/t Toxic Agents
 ;;^UTILITY(U,$J,358.3,14260,1,4,0)
 ;;=4^G62.2
 ;;^UTILITY(U,$J,358.3,14260,2)
 ;;=^268531
 ;;^UTILITY(U,$J,358.3,14261,0)
 ;;=G62.82^^83^822^108
 ;;^UTILITY(U,$J,358.3,14261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14261,1,3,0)
 ;;=3^Neuropathy,Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,14261,1,4,0)
 ;;=4^G62.82
 ;;^UTILITY(U,$J,358.3,14261,2)
 ;;=^5004077
 ;;^UTILITY(U,$J,358.3,14262,0)
 ;;=G62.9^^83^822^120
 ;;^UTILITY(U,$J,358.3,14262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14262,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,14262,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,14262,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,14263,0)
 ;;=G57.90^^83^822^113
 ;;^UTILITY(U,$J,358.3,14263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14263,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,14263,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,14263,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,14264,0)
 ;;=G56.90^^83^822^115
 ;;^UTILITY(U,$J,358.3,14264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14264,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Upper Limb,Unspec
 ;;^UTILITY(U,$J,358.3,14264,1,4,0)
 ;;=4^G56.90
 ;;^UTILITY(U,$J,358.3,14264,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,14265,0)
 ;;=R29.5^^83^822^121
 ;;^UTILITY(U,$J,358.3,14265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14265,1,3,0)
 ;;=3^Paralysis,Transient
 ;;^UTILITY(U,$J,358.3,14265,1,4,0)
 ;;=4^R29.5
 ;;^UTILITY(U,$J,358.3,14265,2)
 ;;=^5019316
 ;;^UTILITY(U,$J,358.3,14266,0)
 ;;=G83.9^^83^822^122
 ;;^UTILITY(U,$J,358.3,14266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14266,1,3,0)
 ;;=3^Paralytic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,14266,1,4,0)
 ;;=4^G83.9
 ;;^UTILITY(U,$J,358.3,14266,2)
 ;;=^5004151
 ;;^UTILITY(U,$J,358.3,14267,0)
 ;;=G82.20^^83^822^123
 ;;^UTILITY(U,$J,358.3,14267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14267,1,3,0)
 ;;=3^Paraplegia,Unspec
 ;;^UTILITY(U,$J,358.3,14267,1,4,0)
 ;;=4^G82.20
 ;;^UTILITY(U,$J,358.3,14267,2)
 ;;=^5004125
 ;;^UTILITY(U,$J,358.3,14268,0)
 ;;=G21.9^^83^822^125
 ;;^UTILITY(U,$J,358.3,14268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14268,1,3,0)
 ;;=3^Parkinsonism,Secondary,Unspec
 ;;^UTILITY(U,$J,358.3,14268,1,4,0)
 ;;=4^G21.9
 ;;^UTILITY(U,$J,358.3,14268,2)
 ;;=^5003778
 ;;^UTILITY(U,$J,358.3,14269,0)
 ;;=G20.^^83^822^124
 ;;^UTILITY(U,$J,358.3,14269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14269,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,14269,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,14269,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,14270,0)
 ;;=G14.^^83^822^128
 ;;^UTILITY(U,$J,358.3,14270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14270,1,3,0)
 ;;=3^Postpolio Syndrome
 ;;^UTILITY(U,$J,358.3,14270,1,4,0)
 ;;=4^G14.
 ;;^UTILITY(U,$J,358.3,14270,2)
 ;;=^5003769
 ;;^UTILITY(U,$J,358.3,14271,0)
 ;;=G45.2^^83^822^129
 ;;^UTILITY(U,$J,358.3,14271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14271,1,3,0)
 ;;=3^Precerebral Artery Syndromes,Multiple/Bilateral
 ;;^UTILITY(U,$J,358.3,14271,1,4,0)
 ;;=4^G45.2
 ;;^UTILITY(U,$J,358.3,14271,2)
 ;;=^5003957
 ;;^UTILITY(U,$J,358.3,14272,0)
 ;;=G12.22^^83^822^130
 ;;^UTILITY(U,$J,358.3,14272,1,0)
 ;;=^358.31IA^4^2
